Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's ...
A COVID-19 vaccine developed using the technology cleared a phase 1 proof-of-concept study in Australia, but Vicebio is focusing first on RSV, with clinical trials of VXB-211 scheduled to in the ...
and founding investor Medicxi – will go in part towards clinical testing of Vicebio's lead vaccine VXB-241 for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), which is in ...
Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study ...
A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...